Published Online: Nov 07, 2019
Page range: 223 - 228
Received: Aug 31, 2018
Accepted: Sep 04, 2018
DOI: https://doi.org/10.2478/sjecr-2018-0033
Keywords
© 2019 Marina Jovanovic et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
When it comes to tumor immunology, understanding of molecular pathways is rather important. During oncogenesis, many molecules should be taken in consideration altogether in context of a single malignancy. It is of a great significance to determine whether these molecules act synergistically or contrary, whether to understand a malignant disease more thoroughly, or even more important, to reveal new approaches of therapy. In this review, we discuss whether and how IL-33/ST2 and PD-1/PDL axis involve in antitumor immunity.